Hodgkin Lymphoma News

Roundup and non-Hodgkin’s lymphoma: Research and more - Medical News Today

Roundup and non-Hodgkin’s lymphoma: Research and more Medical News Today

A Cardio-Obstetric Breakthrough Beyond Routine Pregnancy Care: Unmasking Hodgkin’s Lymphoma - JACC Journals

A Cardio-Obstetric Breakthrough Beyond Routine Pregnancy Care: Unmasking Hodgkin’s Lymphoma JACC Journals

FDA Approves Nivolumab (Opdivo) Combination for Classical Hodgkin Lymphoma - Oncology News Central

FDA Approves Nivolumab (Opdivo) Combination for Classical Hodgkin Lymphoma Oncology News Central

New treatment combination offers excellent results for early-stage Hodgkin lymphoma with less chemotherapy - UT MD Anderson

New treatment combination offers excellent results for early-stage Hodgkin lymphoma with less chemotherapy UT MD Anderson

Nodular lymphocyte-predominant Hodgkin lymphoma: Leah's story - Roswell Park Comprehensive Cancer Center

Nodular lymphocyte-predominant Hodgkin lymphoma: Leah's story Roswell Park Comprehensive Cancer Center

Genome-scale spatial mapping of the Hodgkin lymphoma microenvironment identifies tumor cell survival factors - Nature

Genome-scale spatial mapping of the Hodgkin lymphoma microenvironment identifies tumor cell survival factors Nature

Woman, 26, with excessive itching diagnosed herself with cancer after being dismissed by doctors - UNILAD

Woman, 26, with excessive itching diagnosed herself with cancer after being dismissed by doctors UNILAD

Progress in the Treatment of Advanced-Stage Classical Hodgkin Lymphoma in the PET-Adapted Era - CancerNetwork

Progress in the Treatment of Advanced-Stage Classical Hodgkin Lymphoma in the PET-Adapted Era CancerNetwork

Low-Dose Nivolumab Offers Novel Strategy for Hodgkin Lymphoma Treatment - Targeted Oncology

Low-Dose Nivolumab Offers Novel Strategy for Hodgkin Lymphoma Treatment Targeted Oncology

Nivolumab Plus AVD Reduces Disease Progression Risk in Adolescents With Advanced Classical Hodgkin Lymphoma - The ASCO Post

Nivolumab Plus AVD Reduces Disease Progression Risk in Adolescents With Advanced Classical Hodgkin Lymphoma The ASCO Post

US FDA approves Bristol Myers Squibb's cancer drug for Hodgkin's lymphoma - Reuters

US FDA approves Bristol Myers Squibb's cancer drug for Hodgkin's lymphoma Reuters

Bristol-Myers Squibb Gets FDA Approval for Hodgkin’s Lymphoma Treatment - Yahoo Finance

Bristol-Myers Squibb Gets FDA Approval for Hodgkin’s Lymphoma Treatment Yahoo Finance

Report: Counties that spray the most glyphosate have higher non-Hodgkin lymphoma rates - Iowa Capital Dispatch

Report: Counties that spray the most glyphosate have higher non-Hodgkin lymphoma rates Iowa Capital Dispatch

Learn About How Survival Rates Are Improving With Hodgkin Disease - Verywell Health

Learn About How Survival Rates Are Improving With Hodgkin Disease Verywell Health

Woman able to understand cancer diagnosis thanks to ‘Grey’s Anatomy’ - Tioga Publishing

Woman able to understand cancer diagnosis thanks to ‘Grey’s Anatomy’ Tioga Publishing

Non-Hodgkin lymphoma survivor thankful for clinical trial - UT MD Anderson

Non-Hodgkin lymphoma survivor thankful for clinical trial UT MD Anderson

Distinct cell state ecosystems for nodular lymphocyte-predominant Hodgkin lymphoma - Nature

Distinct cell state ecosystems for nodular lymphocyte-predominant Hodgkin lymphoma Nature

Stage IV non-Hodgkin lymphoma survivor: Why I’m excited about UT MD Anderson coming to Austin - UT MD Anderson

Stage IV non-Hodgkin lymphoma survivor: Why I’m excited about UT MD Anderson coming to Austin UT MD Anderson

Levofloxacin for the prevention of febrile episodes in non-Hodgkin lymphoma patients treated with CHOP plus rituximab in a randomized controlled trial - Nature

Levofloxacin for the prevention of febrile episodes in non-Hodgkin lymphoma patients treated with CHOP plus rituximab in a randomized controlled trial Nature

Advanced stage classical Hodgkin lymphoma patients with a positive interim-PET (PET-2) Deauville score 5 after 2 ABVD cycles: a pooled analysis of three multicenter trials - Nature

Advanced stage classical Hodgkin lymphoma patients with a positive interim-PET (PET-2) Deauville score 5 after 2 ABVD cycles: a pooled analysis of three multicenter trials Nature

Sintilimab combined with AVD for the treatment of composite Hodgkin lymphoma and follicular lymphoma: a case report and literature review - Frontiers

Sintilimab combined with AVD for the treatment of composite Hodgkin lymphoma and follicular lymphoma: a case report and literature review Frontiers

Impact of early failure of induction on transplant outcomes in Hodgkin lymphoma | Bone Marrow Transplantation - Nature

Impact of early failure of induction on transplant outcomes in Hodgkin lymphoma | Bone Marrow Transplantation Nature

‘The Sister Act’: How family and faith helped a young woman beat Hodgkin’s lymphoma - University of California - Davis Health

‘The Sister Act’: How family and faith helped a young woman beat Hodgkin’s lymphoma University of California - Davis Health

Axi-Cel Shows Durable Responses, Curative Hope in Non-Hodgkin Lymphoma - Targeted Oncology

Axi-Cel Shows Durable Responses, Curative Hope in Non-Hodgkin Lymphoma Targeted Oncology

A Rare Case of Non-Hodgkin Lymphoma of the Tracheobronchial Tree - Cureus

A Rare Case of Non-Hodgkin Lymphoma of the Tracheobronchial Tree Cureus

Durable 3-Year Superiority of N-AVD in Advanced Hodgkin Lymphoma - Targeted Oncology

Durable 3-Year Superiority of N-AVD in Advanced Hodgkin Lymphoma Targeted Oncology

Young mother’s Hodgkin lymphoma diagnosis felt ‘devastating’ - Fred Hutchinson Cancer Center

Young mother’s Hodgkin lymphoma diagnosis felt ‘devastating’ Fred Hutchinson Cancer Center

T-Cell Therapy EB103 Demonstrates Safety in B-Cell Non-Hodgkin Lymphoma - Targeted Oncology

T-Cell Therapy EB103 Demonstrates Safety in B-Cell Non-Hodgkin Lymphoma Targeted Oncology

Antibody-Based Therapies for the Treatment of Hodgkin Lymphoma in Older Patients - ASCO Publications

Antibody-Based Therapies for the Treatment of Hodgkin Lymphoma in Older Patients ASCO Publications

First-Line Options in Advanced-Stage Classical Hodgkin Lymphoma: Weighing Efficacy, Toxicity, and Quality of Life in Decision-Making - ASCO Daily News

First-Line Options in Advanced-Stage Classical Hodgkin Lymphoma: Weighing Efficacy, Toxicity, and Quality of Life in Decision-Making ASCO Daily News

Miami F Marcus Allen has non-Hodgkin lymphoma, out for season - ESPN

Miami F Marcus Allen has non-Hodgkin lymphoma, out for season ESPN

Breast Mass as an Atypical Presentation of Non-Hodgkin Lymphoma - Cureus

Breast Mass as an Atypical Presentation of Non-Hodgkin Lymphoma Cureus

New Phase 3 Clinical Trial Opens for Pediatric, Adult Hodgkin Lymphoma Patients - Roswell Park Comprehensive Cancer Center

New Phase 3 Clinical Trial Opens for Pediatric, Adult Hodgkin Lymphoma Patients Roswell Park Comprehensive Cancer Center

Transformation of Classical Hodgkin Lymphoma Into Non-Hodgkin Lymphoma: Three Case Reports From the West Bank - Wiley Online Library

Transformation of Classical Hodgkin Lymphoma Into Non-Hodgkin Lymphoma: Three Case Reports From the West Bank Wiley Online Library